Analysed SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS) News Sources
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
09-09-2026
yahoo.com
VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Collaboration is the 3rd Recent Agreement in the Human Space.
14-09-2026
yahoo.com
Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players
16-09-2026
yahoo.com
What is the current price of SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS)?
The current price of SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS) is $11.75.
SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS) since the previous trading day is $-0.08.
SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS) since the previous trading day is -0.6762%.
What is the most recent average sentiment score for SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS)?
The most recent average sentiment score for SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS) is 74 out of 100.
What is the most recent average sentiment for SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS)?
The most recent sentiment for SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS) is .
SEC-8K** Filing Available For SYSMEX CORP-UNSPON ADR (SSMXY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.